chr4-161459292-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_020116.5(FSTL5):āc.1636A>Gā(p.Lys546Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,818 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_020116.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FSTL5 | NM_020116.5 | c.1636A>G | p.Lys546Glu | missense_variant | 14/16 | ENST00000306100.10 | NP_064501.2 | |
FSTL5 | NM_001128427.3 | c.1633A>G | p.Lys545Glu | missense_variant | 14/16 | NP_001121899.1 | ||
FSTL5 | NM_001128428.3 | c.1606A>G | p.Lys536Glu | missense_variant | 13/15 | NP_001121900.1 | ||
FSTL5 | XM_011532126.1 | c.1609A>G | p.Lys537Glu | missense_variant | 13/15 | XP_011530428.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FSTL5 | ENST00000306100.10 | c.1636A>G | p.Lys546Glu | missense_variant | 14/16 | 1 | NM_020116.5 | ENSP00000305334.4 | ||
FSTL5 | ENST00000379164.8 | c.1633A>G | p.Lys545Glu | missense_variant | 14/16 | 1 | ENSP00000368462.4 | |||
FSTL5 | ENST00000427802.2 | c.1606A>G | p.Lys536Glu | missense_variant | 13/15 | 1 | ENSP00000389270.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460818Hom.: 0 Cov.: 29 AF XY: 0.00000138 AC XY: 1AN XY: 726798
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2024 | The c.1636A>G (p.K546E) alteration is located in exon 14 (coding exon 13) of the FSTL5 gene. This alteration results from a A to G substitution at nucleotide position 1636, causing the lysine (K) at amino acid position 546 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at